198 related articles for article (PubMed ID: 21170080)
1. Effects of formoterol-budesonide on airway remodeling in patients with moderate asthma.
Wang K; Liu CT; Wu YH; Feng YL; Bai HL; Ma ES; Wen FQ
Acta Pharmacol Sin; 2011 Jan; 32(1):126-32. PubMed ID: 21170080
[TBL] [Abstract][Full Text] [Related]
2. Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma.
Kelly MM; O'Connor TM; Leigh R; Otis J; Gwozd C; Gauvreau GM; Gauldie J; O'Byrne PM
J Allergy Clin Immunol; 2010 Feb; 125(2):349-356.e13. PubMed ID: 19969339
[TBL] [Abstract][Full Text] [Related]
3. The effect of inhaled budesonide and formoterol on bronchial remodeling and HRCT features in young asthmatics.
Capraz F; Kunter E; Cermik H; Ilvan A; Pocan S
Lung; 2007; 185(2):89-96. PubMed ID: 17393237
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.
Aalbers R; Boorsma M; van der Woude HJ; Jonkers RE
Respir Res; 2010 May; 11(1):66. PubMed ID: 20509942
[TBL] [Abstract][Full Text] [Related]
5. Budesonide/formoterol decreases expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 within airway remodelling in asthma.
Wang K; Liu CT; Wu YH; Feng YL; Bai HL
Adv Ther; 2008 Apr; 25(4):342-54. PubMed ID: 18421428
[TBL] [Abstract][Full Text] [Related]
6. Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: effects on eosinophilic airway inflammation.
Takeyama K; Kondo M; Tagaya E; Kirishi S; Ishii M; Ochiai K; Isono K; Tamaoki J
Allergy Asthma Proc; 2014; 35(2):141-7. PubMed ID: 24717791
[TBL] [Abstract][Full Text] [Related]
7. Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol.
Pavord ID; Jeffery PK; Qiu Y; Zhu J; Parker D; Carlsheimer A; Naya I; Barnes NC
J Allergy Clin Immunol; 2009 May; 123(5):1083-9, 1089.e1-7. PubMed ID: 19368965
[TBL] [Abstract][Full Text] [Related]
8. Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma.
Hoshino M; Ohtawa J
Respirology; 2012 May; 17(4):639-46. PubMed ID: 22248352
[TBL] [Abstract][Full Text] [Related]
9. An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study.
Price D; Haughney J; Lloyd A; Hutchinson J; Plumb J
Curr Med Res Opin; 2004 Oct; 20(10):1671-9. PubMed ID: 15462701
[TBL] [Abstract][Full Text] [Related]
10. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.
Atienza T; Aquino T; Fernández M; Boonsawat W; Kawai M; Kudo T; Ekelund J; Ivanov S; Carlsson LG
Respirology; 2013 Feb; 18(2):354-63. PubMed ID: 23126237
[TBL] [Abstract][Full Text] [Related]
11. Effect of formoterol with or without budesonide in repeated low-dose allergen challenge.
Dahlén B; Lantz AS; Ihre E; Skedinger M; Henriksson E; Jörgensen L; Ekström T; Dahlén SE; Larsson K
Eur Respir J; 2009 Apr; 33(4):747-53. PubMed ID: 19129280
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
[TBL] [Abstract][Full Text] [Related]
13. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety.
Bodzenta-Lukaszyk A; Buhl R; Balint B; Lomax M; Spooner K; Dissanayake S
J Asthma; 2012 Dec; 49(10):1060-70. PubMed ID: 23102189
[TBL] [Abstract][Full Text] [Related]
14. Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study.
FitzGerald JM; Sears MR; Boulet LP; Becker AB; McIvor AR; Ernst P; Smiljanic-Georgijev NM; Lee JS;
Can Respir J; 2003; 10(8):427-34. PubMed ID: 14679407
[TBL] [Abstract][Full Text] [Related]
15. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study.
Lundborg M; Wille S; Bjermer L; Tilling B; Lundgren M; Telg G; Ekström T; Selroos O
Curr Med Res Opin; 2006 May; 22(5):809-21. PubMed ID: 16709303
[TBL] [Abstract][Full Text] [Related]
16. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
Akamatsu T; Shirai T; Kato M; Yasui H; Hashimoto D; Fujisawa T; Tsuchiya T; Inui N; Suda T; Chida K
Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566
[TBL] [Abstract][Full Text] [Related]
17. Budesonide/formoterol effects on metalloproteolytic balance in TGFbeta-activated human lung fibroblasts.
Todorova L; Gürcan E; Westergren-Thorsson G; Miller-Larsson A
Respir Med; 2009 Nov; 103(11):1755-63. PubMed ID: 19375904
[TBL] [Abstract][Full Text] [Related]
18. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.
Tal A; Simon G; Vermeulen JH; Petru V; Cobos N; Everard ML; de Boeck K
Pediatr Pulmonol; 2002 Nov; 34(5):342-50. PubMed ID: 12357478
[TBL] [Abstract][Full Text] [Related]
19. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma.
Wilson SJ; Wallin A; Della-Cioppa G; Sandström T; Holgate ST
Am J Respir Crit Care Med; 2001 Sep; 164(6):1047-52. PubMed ID: 11587995
[TBL] [Abstract][Full Text] [Related]
20. Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study.
Aalbers R
Clin Drug Investig; 2010; 30(7):439-51. PubMed ID: 20528000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
